Align Technology, Inc. Share Price and Company Fundamentals
Last traded: Last Friday at 8:00 PM
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Key Metrics
PE ratio
29.07
PB ratio
2.89
Dividend yield
-
Beta
1.82
Market cap
$11.78B
Enterprise value
$10.73B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Full time employees | 20290 |
| Website | https://www.aligntech.com |
| Mailing address | 410 North Scottsdale Road Suite 1300 Tempe AZ 85288 United States |
| Phone / Fax | 602 742 2000 / |
Dividends
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Align Technology, Inc. paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ALGN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Align Technology, Inc..
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Joseph M. Hogan | President, CEO & Director | 68 | |
| Mr. John F. Morici | CFO & Executive VP of Global Finance | 58 | |
| Ms. Julie Ann Coletti J.D. | Executive VP and Chief Legal & Regulatory Officer | 57 | |
| Mr. Stuart Hockridge | Executive Vice President of Global Human Resources | 53 | |
| Mr. Emory M. Wright | Executive Vice President of Direct Fabrication Platform & Operations | 55 | |
| Mr. Zelko Relic | Executive VP & CTO | 60 | |
| Ms. Shirley Stacy | Vice President of Corporate Communications & Investor Relations | ||
| Ms. Sreelakshmi Kolli | Executive VP and Chief Product & Digital Officer | 50 | |
| Mr. Srini Kaza | Executive Vice President of Research & Development | ||
| Dr. Mitra Derakhshan | Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services |
Profitability and management effectiveness
Profit margin
10.17%
Operating margin
22.38%
Return on assets
6.94%
Return on equity
10.39%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Align Technology, Inc. is 11.78B and its enterprise value is 10.73B. The enterprise value to revenue ratio of ALGN is 2.66. The enterprise value to EBITDA ratio of ALGN is 12.60.
The ALGN's stocks Beta value is 1.82 making it 82% more volatile compared to NASDAQ market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Align Technology, Inc. (NASDAQ:ALGN) Frequently Asked Questions
1. What is Align Technology, Inc.'s Stock Symbol?
Align Technology, Inc. trades on NASDAQ under the ticker symbol "ALGN".
2. What is Align Technology, Inc.'s stock price today?
One share of ALGN stock can currently be purchased for approximately $164.23.
3. How can I contact Align Technology, Inc.?
Align Technology, Inc.'s mailing address is 410 North Scottsdale Road Suite 1300 Tempe AZ 85288 United States. The company can be reached via phone at 602 742 2000.
4. What is Align Technology, Inc.'s official website?
The official website of Align Technology, Inc. is https://www.aligntech.com.